Endometriosis: What is the Influence of Immune Cells?

References

• Agic A, Djalali S, Diedrich K, Hornung D. 2009. Apoptosis in endometriosis. Gynecol Obstet Invest. 68:217–33.
   PubMed Web of Science ®Google Scholar
• Ahn SH, Monsanto SP, Miller C, Singh SS, Thomas R, Tayade C. 2015. Pathophysiology and immune dysfunction in endometriosis. Biomed Res Int. 2015:795976.
   PubMed Web of Science ®Google Scholar
• Akoum A, Lawson C, McColl S, Villeneuve M. 2001. Ectopic endometrial cells express high concentrations of interleukin (IL)-8 in vivo regardless of the menstrual cycle phase and respond to oestradiol by up-regulating IL-1-induced IL-8 expression in vitro. Mol Hum Reprod. 7(9):859–66.
   PubMed Web of Science ®Google Scholar
• Augoulea A, Mastorakos G, Lambrinoudaki I, Christodoulakos G, Creatsas G. 2009. The role of the oxidative-stress in the endometriosis-related infertility. Gynecol Endocrinol. 25(2):75–81.
   PubMed Web of Science ®Google Scholar
• Bałkowiec M, Maksym RB, Włodarski PK. 2018. The bimodal role of matrix metalloproteinases and their inhibitors in etiology and pathogenesis of endometriosis. Mol Med Rep. 18:3123–36.
   PubMed Web of Science ®Google Scholar
• Baranov V, Malysheva O, Yarmolinskaya M. 2018 23. Pathogenomics of endometriosis development. Int J Mol Sci. 19(7):1852. doi:10.3390/ijms19071852.
   Web of Science ®Google Scholar
• Berbic M, Fraser IS. 2011. Regulatory T cells and other leukocytes in the pathogenesis of endometriosis. J Reprod Immunol. 88:149–55.
   PubMed Web of Science ®Google Scholar
• Bontis JN, Vavilis DT. 1997. Etiopathology of endometriosis. Ann N Y Acad Sci. 816:305–09.
   PubMed Web of Science ®Google Scholar
• Borghese B, Zondervan KT, Abrao MS, Chapron C, Vaiman D. 2017. Recent insights on the genetics and epigenetics of endometriosis. Clin Genet. 91(2):254–64.
   PubMed Web of Science ®Google Scholar
• Cabal-Hierro L, Lazo PS. 2012. Signal transduction by tumor necrosis factor receptors. Cell Signal. 24(6):1297–305.
   PubMed Web of Science ®Google Scholar
• Cakmak H, Guzeloglu-Kayisli O, Kayisli UA, Arici A. 2009. Immune‐endocrine interactions in endometriosis. Front Biosci (Elite Ed). 1:429–43.
   PubMedGoogle Scholar
• Chamié LP, Ribeiro DMFR, Tiferes DA, Macedo Neto AC, Serafini PC. 2018. Atypical sites of deeply infiltrative endometriosis: clinical characteristics and imaging findings. Radiographics. 38(1):309–28.
   PubMed Web of Science ®Google Scholar
• Chene G, Ouellet V, Rahimi K, Barres V, Provencher D, Mes-Masson AM. 2015. The ARID1A pathway in ovarian clear cell and endometrioid carcinoma, contiguous endometriosis, and benign endometriosis. Int J Gynaecol Obstet. 130(1):27–30.
   PubMed Web of Science ®Google Scholar
• Chiang AJ, Chang C, Huang CH, Huang WC, Kan YY, Chen J. 2018. Risk factors in progression from endometriosis to ovarian cancer: a cohort study based on medical insurance data. J Gynecol Oncol. 29(3):e28.
   PubMed Web of Science ®Google Scholar
• Christodoulakos G, Augoulea A, Lambrinoudaki I, Sioulas V, Creatsas G. 2007. Pathogenesis of endometriosis: the role of defective ‘immunosurveillance’. Eur J Contracept Reprod Health Care. 12:194–202.
   PubMed Web of Science ®Google Scholar
• Colón-Díaz M, Báez-Vega P, García M, Ruiz A, Monteiro JB, Fourquet J, Bayona M, Alvarez-Garriga C, Achille A, Seto E, et al. 2012. HDAC1 and HDAC2 aredifferentially expressed in endometriosis. Reprod Sci. 19(5):483–92.
   PubMed Web of Science ®Google Scholar
• Dawson A, Fernandez ML, Anglesio M, Yong PJ, Carey MS. 2018. Endometriosis and endometriosis-associated cancers: new insights into the molecular mechanisms of ovarian cancer development. Ecancermedicalscience. 25;12:803.
   Web of Science ®Google Scholar
• de Paula Andres M, Borrelli GM, Kho RM, Abrão MS. 2017. The current management of deep endometriosis: a systematic review. Minerva Ginecol. 69(6):587–96.
   PubMed Web of Science ®Google Scholar
• Dunselman GA, Vermeulen N, Becker C, Calhaz-Jorge C, D’Hooghe T, De Bie B, Heikinheimo O, Horne AW, Kiesel L, Nap A, et al.; European Society of Human Reproduction and Embryology. 2014. ESHRE guideline: management of women with endometriosis. Hum Reprod. 29:400–12.
   PubMed Web of Science ®Google Scholar
• Gallinelli A, Chiossi G, Giannella L, Marsella T, Genazzani AD, Volpe A. 2004. Different concentrations of interleukins in the peritoneal fluid of women with endometriosis: relationships with lymphocyte subsets. Gynecol Endocrinol. 18:144–51.
   PubMed Web of Science ®Google Scholar
• Gazvani R, Templeton A. 2002. Peritoneal environment, cytokines and angiogenesis in the pathophysiology of endometriosis. Reproduction. 123(2):217–26.
   PubMed Web of Science ®Google Scholar
• Gebel HM, Braun DP, Tambur A, Frame D, Rana N, Dmowski WP. 1998. Spontaneous apoptosis of endometrial tissue is impaired in women with endometriosis. Fertil Steril. 69:1042–47.
   PubMed Web of Science ®Google Scholar
• Giudice LC. 1994. Growth factors and growth modulators in human uterine endometrium: heir potential relevance to reproductive medicine. Fertil Steril. 61(1):1–17.
   PubMed Web of Science ®Google Scholar
• Giudice LC, Kao LC. 2004. Endometriosis. Lancet. 364:1789–99.
   PubMed Web of Science ®Google Scholar
• Goldstein DP, deCholnoky C, Emans SJ, Leventhal JM. 1980. Laparoscopy in the diagnosis and management of pelvic pain in adolescents. J Reprod Med. 24:251–56.
   PubMed Web of Science ®Google Scholar
• Grimstad FW, Decherney A. 2017. A review of the epigenetic contributions to endometriosis. Clin Obstet Gynecol. 60:467–76.
   PubMed Web of Science ®Google Scholar
• Harada T, Taniguchi F, Izawa M, Ohama Y, Takenaka Y, Tagashira Y, Ikeda A, Watanabe A, Iwabe T, Terakawa N. 2007. Apoptosis and endometriosis. Front Biosci. 12:3140–51.
   PubMed Web of Science ®Google Scholar
• He J, Chang W, Feng C, Cui M, Xu T. 2018. Endometriosis malignant transformation: epigenetics as a probable mechanism in ovarian tumorigenesis. Int J Genomics. 27:1465348.
   Google Scholar
• Healey M, Ang WC, Cheng C. 2010. Surgical treatment of endometriosis: a prospective randomized double-blinded trial comparing excision and ablation. Fertil Steril. 94(7):2536–40.
   PubMed Web of Science ®Google Scholar
• Herington JL, Bruner-Tran KL, Lucas JA, Osteen KG. 2011. Immune interactions in endometriosis. Expert Rev Clin Immunol. 7:611–26.
   PubMed Web of Science ®Google Scholar
• Hirata T, Osuga Y, Hamasaki K, Yoshino O, Ito M, Hasegawa A, Takemura Y, Hirota Y, Nose E, Morimoto C, et al. 2008. Interleukin (IL)‐17A stimulates IL‐8 secretion, cyclooxygensase‐2 expression, and cell proliferation of endometriotic stromal cells. Endocrinology. 149:1260–67.
   PubMed Web of Science ®Google Scholar
• Ho HN, Wu MY, Chao KH, Chen CD, Chen SU, Yang YS. 1997. Peritoneal interleukin-10 increases with decrease in activated CD4+ T lymphocytes in women with endometriosis. Hum Reprod. 12(11):2528–33.
   PubMed Web of Science ®Google Scholar
• Iwabe T, Harada T, Sakamoto Y, Iba Y, Horie S, Mitsunari M, Terakawa N. 2003. Gonadotropin-releasing hormone agonist treatment reduced serum interleukin-6 concentrations in patients with ovarian endometriomas. Fertil Steril. 80(2):300–04.
   PubMed Web of Science ®Google Scholar
• Iwabe T, Harada T, Tsudo T, Tanikawa M, Onohara Y, Terakawa N. 1998. Pathogenetic significance of increased levels of interleukin‐8 in the peritoneal fluid of patients with endometriosis. Fertil Steril. 69:924–30.
   PubMed Web of Science ®Google Scholar
• Iwabuchi T, Yoshimoto C, Shigetomi H, Kobayashi H. 2015. Oxidative stress and antioxidant defense in endometriosis and its malignant transformation. Oxid Med Cell Longev. 2015:848595. doi:10.1155/2015/848595.
   PubMed Web of Science ®Google Scholar
• Kalu E, Sumar N, Giannopoulos T, Patel P, Croucher C, Sherriff E, Bansal A. 2007. Cytokine profiles in serum and peritoneal fluid from infertile women with and without endometriosis. J Obstet Gynaecol Res. 33:490–95.
   PubMed Web of Science ®Google Scholar
• Kennedy S, Bergqvist A, Chapron C, D’Hooghe T, Dunselman G, Greb R, Hummelshoj L, Prentice A, Saridogan E; ESHRE Special Interest Group for Endometriosis and Endometrium Guideline Development Group. 2005. ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod. 20:2698–704.
   PubMed Web of Science ®Google Scholar
• Kennedy SH, Sargent IL, Starkey PM, Hicks BR, Barlow DH. 1990. Localization of anti-endometrial antibody binding in women with endometriosis using a double-labelling immunohistochemical method. Br J Obstet Gynaecol. 97(8):671–74.
   PubMedGoogle Scholar
• Kho RM, Andres MP, Borrelli GM, Neto JS, Zanluchi A, Abrão MS. 2018. Surgical treatment of different types of endometriosis: comparison of major society guidelines and preferred clinical algorithms. Best Pract Res Clin Obstet Gynaecol. 51:102–10.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Sumimoto K, Moniwa N, Imai M, Takakura K, Kuromaki T, Morioka E, Arisawa K, Terao T, Morioka E, et al. 2007. Risk of developing ovarian cancer among women with ovarian endometrioma: a cohort study in Shizuoka, Japan. Int J Gynecol Cancer. 17:37–43.
   PubMed Web of Science ®Google Scholar
• Kok VC, Tsai HJ, Su CF, Lee CK. 2015. The risks for ovarian, endometrial, breast, colorectal, and other cancers in women with newly diagnosed endometriosis or adenomyosis: a population-based study. Int J Gynecol Cancer. 25(6):968–76.
   PubMed Web of Science ®Google Scholar
• Kondera-Anasz Z, Sikora J, Mielczarek-Palacz A, Jońca M. 2005 1. Concentrations of interleukin (IL)-1alpha, IL-1 soluble receptor type II (IL-1 sRII) and IL-1 receptor antagonist (IL-1 Ra) in the peritoneal fluid and serum of infertile women with endometriosis. Eur J Obstet Gynecol Reprod Biol. 123(2):198–203. doi:10.1016/j.ejogrb.2005.04.019.
   PubMed Web of Science ®Google Scholar
• Koninckx PR, Ussia A, Adamyan L, Wattiez A, Gomel V, Martin DC. 2019. Pathogenesis of endometriosis: the genetic/epigenetic theory. Fertil Steril. 111(2):327–40.
   PubMed Web of Science ®Google Scholar
• Králíčková M, Fiala L, Losan P, Tomes P, Vetvicka V. 2018. Altered immunity in endometriosis: what came first? Immunol Invest. 47(6):569–82.
   PubMed Web of Science ®Google Scholar
• Králíčková M, Laganà AS, Ghezzi F, Vetvicka V. 2020. Endometriosis and risk of ovarian cancer: what do we know? Arch Gynecol Obstet. 301(1):1–10.
   PubMed Web of Science ®Google Scholar
• Králíčková M, Vetvicka V. 2015. Immunological aspects of endometriosis: a review. Ann Transl Med. 3(11):153.
   PubMed Web of Science ®Google Scholar
• Kumar S, Munkarah A, Arabi H, Bandyopadhyay S, Semaan A, Hayek K, Garg G, Morris R, Ali-Fehmi R. 2011. Prognostic analysis of ovarian cancer associated with endometriosis. Am J Obstet Gynecol. 204(1):63.e1–7.
   PubMed Web of Science ®Google Scholar
• Kurman RJ, Shih I. 2008. Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications. Int J Gynecol Pathol. 27(2):151–60.
   PubMed Web of Science ®Google Scholar
• Laganà AS, Garzon S, Götte M, Viganò P, Franchi M, Ghezzi F, Martin DC. 2019a Nov 10. The pathogenesis of endometriosis: molecular and cell biology insights. Int J Mol Sci. 20(22). doi:10.3390/ijms20225615.
   PubMed Web of Science ®Google Scholar
• Laganà AS, Salmeri FM, Ban Frangež H, Ghezzi F, Vrtačnik-Bokal E, Granese R. 2019b Oct. Evaluation of M1 and M2 macrophages in ovarian endometriomas from women affected by endometriosis at different stages of the disease. Gynecol Endocrinol. 30:1–4.
   Google Scholar
• Laganà AS, Vitale SG, Salmeri FM, Triolo O, Ban Frangež H, Vrtačnik-Bokal E, Stojanovska L, Apostolopoulos V, Granese R, Sofo V. 2017 June. Unus pro omnibus, omnes pro uno: A novel, evidence-based, unifying theory for the pathogenesis of endometriosis. Med Hypotheses. 103:10–20.
   PubMed Web of Science ®Google Scholar
• Lettau M, Paulsen M, Kabelitz D, Janssen O. 2008. Storage, expression and function of Fas ligand, the key death factor of immune cells. Curr Med Chem. 15:1684–96.
   PubMed Web of Science ®Google Scholar
• Maeda N, Izumiya C, Yamamoto Y, Oguri H, Kusume T, Fukaya T. 2002. Increased killer inhibitory receptor KIR2DL1 expression among natural killer cells in women with pelvic endometriosis. Fertil Steril. 77:297–302.
   PubMed Web of Science ®Google Scholar
• Mahnke JL, Dawood MY, Huang JC. 2000. Vascular endothelial growth factor a interleukin in peritoneal fluid of women with endometriosis. Fertil Steril. 73(1):166–70.
   PubMed Web of Science ®Google Scholar
• Măluţan AM, Drugan T, Ciortea R, Mocan-Hognogi RF, Bucuri C, Rada MP, Mihu D. 2015. Serum anti-inflammatory cytokines for the evaluation of inflammatory status in endometriosis. J Res Med Sci. 20(7):668–74.
   PubMed Web of Science ®Google Scholar
• Mandai M, Yamaguchi K, Matsumura N, Baba T, Konishi I. 2009. Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management. Int J Clin Oncol. 14:383–91.
   PubMed Web of Science ®Google Scholar
• Mao AJ, Anastasi JK. 2010. Diagnosis and management of endometriosis: the role of advanced practice nurse in primary care. J Am Acad Nurse Pract. 22(2):109–16.
   PubMedGoogle Scholar
• Marsh DJ, Shah JS, Cole AJ. 2014. Histones and their modifications in ovarian câncer-drivers of disease and therapeutic targets. Front Oncol. 12;4:144.
   Google Scholar
• Matalliotakis IM, Goumenou AG, Koumantakis GE, Neonaki MA, Koumantakis EE, Dionyssopoulou E, Athanassakis I, Vassiliadis S. 2003. Serum concentrations of growth factors in women with and without endometriosis: the action of anti-endometriosis medicines. Int Immunopharmacol. 3(1):81–89.
   PubMed Web of Science ®Google Scholar
• Miossec P, Korn T, Kuchroo VK. 2009. Interleukin‐17 and type 17 helper T cells. N Engl J Med. 361:888–98.
   PubMed Web of Science ®Google Scholar
• Monsanto SP, Edwards AK, Zhou J, Nagarkatti P, Nagarkatti M, Young SL, Lessey BA, Tayade C. 2016. Surgical removal of endometriotic lesions alters local and systemic proinflammatory cytokines in endometriosis patients. Fertil Steril. 105(4):968–977.e5.
   PubMed Web of Science ®Google Scholar
• Munksgaard PS, Blaakaer J. 2011. The association between endometriosis and gynecological cancers and breast cancer: a review of epidemiological data. Gynecol Oncol. 123(1):157–63.
   PubMed Web of Science ®Google Scholar
• Murphy AA, Santanam N, Morales AJ, Parthasarathy S. 1998 June. Lysophosphatidyl choline, a chemotactic factor for monocytes/T-lymphocytes is elevated in endometriosis. J Clin Endocrinol Metab. 83(6):2110–13.
   PubMed Web of Science ®Google Scholar
• National Guideline Alliance (UK). 2017. Endometriosis: diagnosis and management. London (UK): National Institute for Health and Care Excellence (UK).
   Google Scholar
• Nguyen HT, Tian G, Murph MM. 2014 8. Molecular epigenetics in the management of ovarian cancer: are we investigating a rational clinical promise? Front Oncol. 4:71.
   PubMedGoogle Scholar
• Nisolle M, Donnez J. 1997. Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities. Fertil Steril. 68(4):585–96.
   PubMed Web of Science ®Google Scholar
• Ohata Y, Harada T, Miyakoda H, Taniguchi F, Iwabe T, Terakawa N. 2008. Serum interleukin‐8 levels are elevated in patients with ovarian endometrioma. Fertil Steril. 90:994–99.
   PubMed Web of Science ®Google Scholar
• Olovsson M. 2011. Immunological aspects of endometriosis: an update. Am J Reprod Immunol. 66(Suppl 1):101–04.
   PubMedGoogle Scholar
• Oosterlynck DJ, Cornillie FJ, Waer M, Vandeputte M, Koninckx PR. 1991. Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium. Fertil Steril. 56(1):45–51.
   PubMed Web of Science ®Google Scholar
• Osuga Y, Koga K, Hirota Y, Hirata T, Yoshino O, Taketani Y. 2011. Lymphocytes in endometriosis. Am J Reprod Immunol. 65:1–10.
   PubMed Web of Science ®Google Scholar
• Othman E-D, Hornung D, Salem HT, Khalifa EA, El-Metwally TH, Al-Hendy A. 2008. Serum cytokines as biomarkers for nonsurgical prediction of endometriosis. Eur J Obstet Gynecol Reprod Biol. 137(2):240–46.
   PubMed Web of Science ®Google Scholar
• Paik ES, Kim TJ, Choi CH, Kim BG, Bae DS, Lee JW. 2018. Clinical outcomes of patients with clear cell and endometrioid ovarian cancer arising from endometriosis. J Gynecol Oncol. 29(2):e18.
   PubMed Web of Science ®Google Scholar
• Pontikaki A, Sifakis S, Spandidos DA. 2016. Endometriosis and breast cancer: a survey of the epidemiological studies. Oncol Lett. 11(1):23–30.
   PubMed Web of Science ®Google Scholar
• Revised American society for reproductive medicine classification of endometriosis: 1996. 1997. Fertil Steril. 67(5):817–21. doi:10.1016/S0015-0282(97)81391-X.
   PubMed Web of Science ®Google Scholar
• Ruderman R, Pavone ME. 2017. Ovarian cancer in endometriosis: an update on the clinical and molecular aspects. Minerva Ginecol. 69(3):286–94.
   PubMed Web of Science ®Google Scholar
• Rutella S, Danese S, Leone G. 2006 Jan. Tolerogenic dendritic cells: cytokine modulation comes of age. Blood. 108(5):1435–40.
   PubMed Web of Science ®Google Scholar
• Saavalainen L, Lassus H, But A, Tiitinen A, Härkki P, Gissler M, Heikinheimo O, Pukkala E. 2018 Jan. A nationwide cohort study on the risk of non-gynaecological cancers in women with surgically verified endometriosis. Int J Cancer. 143(11):2725–31.
   PubMed Web of Science ®Google Scholar
• Salmeri FM, Laganà AS, Sofo V, Triolo O, Sturlese E, Retto G, Pizzo A, D’Ascola A, Campo S. 2015. Behavior of tumor necrosis factor-α and tumor necrosis factor receptor 1/tumor necrosis factor receptor 2 system in mononuclear cells recovered from peritoneal fluid of women with endometriosis at different stages. Reprod Sci. 22(2):165–72.
   PubMed Web of Science ®Google Scholar
• Sampson JA. 1921. Perforating hemorrhagic (chocolate) cysts of the ovary. Their importance and especially their relation to pelvic adenomas of the endometrial type. Arch Surg. 3:245–323.
   Google Scholar
• Sampson JA. 1925. Endometrial carcinoma of the ovary, arising in endometrial tissue in that organ. Arch Surg. 10(1):1–72.
   Google Scholar
• Sampson JA. 1927. Metastatic or embolic endometriosis, due to the menstrual dissemination of endometrial tissue into the venous circulation. Am J Pathol. 3:93–110.
   PubMedGoogle Scholar
• Sbracia M, Valeri C, Antonini G, Biagiotti G, Pacchiarotti A, Pacchiarotti A. 2016. Fas and Fas-ligand in eutopic and ectopic endometrium of women with endometriosis: the possible immune privilege of ectopic endometrium. Reprod Sci. 23:81–86.
   PubMed Web of Science ®Google Scholar
• Scurry J, Whitehead J, Healey M. 2001. Classification of ovarian endometriotic cysts. Int J Gynecol Pathol. 20(2):147–54.
   PubMed Web of Science ®Google Scholar
• Sikora J, Mielczarek-Palacz A, Kondera-Anasz Z. 2011. Role of natural killer cell activity in the pathogenesis of endometriosis. Curr Med Chem. 18(2):200–08.
   PubMed Web of Science ®Google Scholar
• Stamenkovic I. 2003. Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol. 200:448–64.
   PubMed Web of Science ®Google Scholar
• Strasser A, Jost PJ, Nagata S. 2009. The many roles of Fas receptor signalling in the immune system. Immunity. 30:180–92.
   PubMed Web of Science ®Google Scholar
• Suen JL, Chang Y, Chiu PR, Hsieh TH, Hsi E, Chen YC, Chen YF, Tsai EM. 2014. Serum level of IL-10 is increased in patients with endometriosis, and IL-10 promotes the growth of lesions in a murine model. Am J Pathol. 184(2):464–71.
   PubMed Web of Science ®Google Scholar
• Szamatowicz M. 2008. Endometriosis: still an enigmatic disease - what are the causes, how to diagnose it and how to treat successfully? Gynecol Endocrinol. 24(10):535–36.
   PubMed Web of Science ®Google Scholar
• Szymanowski K. 2007. Apoptosis pattern in human endometrium in women with pelvic endometriosis. Eur J Obstet Gynecol Reprod Biol. 132:107–10.
   PubMed Web of Science ®Google Scholar
• Tariverdian N, Siedentopf F, Rücke M, Blois SM, Klapp BF, Kentenich H, Arck PC. 2009. Intraperitoneal immune cell status in infertile women with and without endometriosis. J Reprod Immunol. 80:80–90.
   PubMed Web of Science ®Google Scholar
• Taylor RN, Lebovic DI, Mueller MD. 2002. Angiogenic factors in endometriosis. Ann N Y Acad Sci. 955:89–100.
   PubMed Web of Science ®Google Scholar
• Tsudo T, Harada T, Iwabe T, Tanikawa M, Nagano Y, Ito M, Taniguchi F, Terakawa N. 2000. Altered gene expression and secretion of interleukin 6 in stromal cells derived from endometriotic tissues. Fertil Steril. 73(2):205–11.
   PubMed Web of Science ®Google Scholar
• Van Langendonckt A, Casanas-Roux F, Donnez J. 2002 May. Oxidative stress and peritoneal endometriosis. Fertil Steril. 77(5):861–70.
   PubMed Web of Science ®Google Scholar
• Vercellini P, Crosignani P, Somigliana E, Viganò P, Frattaruolo MP, Fedele L. 2011. ‘Waiting for Godot’: a commonsense approach to the medical treatment of endometriosis. Hum Reprod. 26(1):3–13.
   PubMed Web of Science ®Google Scholar
• Vercellini P, Somigliana E, Viganò P, Abbiati A, Barbara G, Crosignani PG. 2009. Endometriosis: current therapies and new pharmacological developments. Drugs. 69(6):649–75.
   PubMed Web of Science ®Google Scholar
• Vercellini P, Viganò P, Somigliana E, Fedele L. 2014. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 10(5):261–75.
   PubMed Web of Science ®Google Scholar
• Vetvicka V, Laganà AS, Salmeri FM, Triolo O, Palmara VI, Vitale SG, Sofo V, Králíčková M. 2016 Nov. Regulation of apoptotic pathways during endometriosis: from the molecular basis to the future perspectives. Arch Gynecol Obstet. 294(5):897–904.
   PubMed Web of Science ®Google Scholar
• Vitale SG, Capriglione S, Peterlunger I, La Rosa VL, Vitagliano A, Noventa M, Valenti G, Sapia F, Angioli R, Lopez S, et al. 2018 Mar. The role of oxidative stress and membrane transport systems during endometriosis: a fresh look at a busy corner. Oxid Med Cell Longev. 21:7924021.
   Google Scholar
• Wei JJ, William J, Bulun S. 2011. Endometriosis and ovarian cancer: a review of clinical, pathologic, and molecular aspects. Int J Gynecol Pathol. 30(6):553–68.
   PubMed Web of Science ®Google Scholar
• Yamaguchi K, Mandai M, Toyokuni S, Hamanishi J, Higuchi T, Takakura K, Fujii S. 2008 Jan. Contents of endometriotic cysts, especially the high concentration of free iron, are a possible cause of carcinogenesis in the cysts through the iron-induced persistent oxidative stress. Clin Cancer Res. 14(1):32–40.
   PubMed Web of Science ®Google Scholar